CBG OIL FAQ

CBG (cannabigerol) is a cannabinoid found in the Cannabis sativa plant. It is considered to be a minor cannabinoid because it is present in such small quantities. CBG is non-intoxicating, and is the precursor molecule to CBD and THC.

CBG works within the endocannabinoid system by interacting with CB1 and CB2 receptors, and may possibly inhibit the psychoactive effects of THC.

CBG Oil has been dubbed the ‘Rolls Royce of cannabinoids’ because there are only small amounts in hemp, making it expensive to extract. CBG content usually makes up about one twentieth of the amount of CBD in a hemp plant.

No. CBG is non-intoxicating.

CBG is under investigation as a potent anti-inflammatory, a stopper of cancer cell proliferation, anti-nauseant, painkiller, and as a treatment for glaucoma. However, these studies are in early stages. We hope to soon find out if CBG can help humans with these conditions. 

According to early studies, CBG seems to have a lot of the pharmacological traits that CBD has. The difference is that CBG acts directly on cannabinoid receptors, but CBD does not. 

CBG is from the plant called Cannabis Sativa. Hemp and ‘marijuana’ are both considered to be of the genus cannabis. And, yes, both contain CBG as a minor cannabinoid. RxLeaf’s KOAL CBG Oil comes from a broad spectrum CBD Oil and CBG isolate. 

CBG can be lawfully produced and extracted under the 2018 Farm Bill. It is not an approved drug by the FDA. This seems to give it a sort of legal loophole. It is important, however, that unapproved health claims are not made about CBG.

Yes. The base is a broad spectrum CBD oil made from organic hemp grown by American farmers. This is rich in cannabinoids and terpenes. To this is added the CBG isolate.

As with CBD oil, you should check the labeling on the bottle for dosage recommendations. Always start on the low side and dose up from there. This will allow your body to adjust to the CBG and you are less likely to experience side effects.